|
Press Releases |
|
|
|
Friday, March 31, 2023 |
|
云康集团公布上市后首份全年业绩 |
领先的中国医学运营服务应供商云康集团有限公司(「云康」或「集团」;股份代号:2325)公布截至2022年12月31日止年度(「报告期」)之上巿后首份全年业绩。 more info >> |
|
云康集团公佈上市後首份全年業績 |
領先的中國醫學運營服務應供商云康集团有限公司(「云康」或「集團」;股份代號:2325)公布截至2022年12月31日止年度(「報告期」)之上巿後首份全年業績。 more info >> |
|
Yunkang Group Announces First Annual Results Since Listing |
Yunkang Group Limited ("Yunkang" or the "Group"; Stock Code: 2325), a leading medical operation services provider in China, has announced its first annual results for the year ended December 31, 2022 (the "Reporting Period") since its listing. more info >> |
|
Wednesday, October 26, 2022 |
|
云康集团(02325.HK)荣获香港股票分析师协会《上市公司年度大奖2022》 |
中国领先医学运营服务提供商-云康集团有限公司(「云康集团」或「集团」)(股票编号:02325.HK)荣获香港股票分析师协会颁发的《上市公司年度大奬2022》,以表扬集团于业务营运及投资者关系工作的卓越表现。 more info >> |
|
雲康集團(02325.HK)榮獲香港股票分析師協會《上市公司年度大奬2022》 |
中國領先醫學運營服務提供商-雲康集團有限公司(「雲康集團」或「集團」)(股票編號:02325.HK)榮獲香港股票分析師協會頒發的《上市公司年度大奬2022》,以表揚集團於業務營運及投資者關係工作的卓越表現。 more info >> |
|
Friday, August 12, 2022 |
|
云康集团公佈上巿後首個中期業績 純利上升50%至人民幣2.34億元 |
領先的中國醫學運營服務應供商云康集团有限公司(「云康」或「集團」;股份代號:2325)公布截至2022年6月30日止(「報告期」)上巿後首個中期業績。 more info >> |
|
Yunkang Group Announces First Interim Results Since Listing, Net Profit Rises 50% to RMB234 Million |
Yunkang Group Limited ("Yunkang" or the "Group"; Stock Code: 2325), a leading medical operation services provider in China, has announced its first interim results for the six months ended 30 June 2022 (the "Reporting Period") since its listing. more info >> |
|
Saturday, May 21, 2022 |
|
云康集团 (02325.HK) 冀为中国医疗系统创新发展 |
新股云康集团(2325)一直致力于深化在医疗领域方面的技术,与不同的机构共同合作,推动科研成果产业化;共同培训高素质人才;改革医疗措施、优化医疗系统方面的效率,提高基层医院的诊断能力及容量,运用长期以来的科研技术带来中国医疗系统的突破。 more info >> |
|
雲康集團 (02325.HK) 冀為中國醫療系統創新發展 |
新股雲康集團(2325)一直致力於深化在醫療領域方面的技術,與不同的機構共同合作,推動科研成果產業化;共同培訓高素質人才;改革醫療措施、優化醫療系統方面的效率,提高基層醫院的診斷能力及容量,運用長期以來的科研技術帶來中國醫療系統的突破。 more info >> |
|
Wednesday, May 18, 2022 |
|
云康集团成功登陆香港交易所主板 |
中国医学运营服务提供商 ── 云康集团有限公司 (「云康集团」或「公司」,股份代号:2325 ),正式登陆香港交易所主板市场,股份代号为2325,每手买卖单位为500股股份。 more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Avance Clinical Showcases Clinical Excellence at World Orphan Drug Conference in Boston, April 23-25
Apr 20, 2024 01:00 HKT/SGT
|
|
|
Brawijaya University researcher develops honey-processing tech
Apr 19, 2024 23:00 HKT/SGT
|
|
|
UK's Largest EV Show Returns for 4th Edition Driving Innovation with Policy Leaders, Product Launches, and EV Innovations
Apr 19, 2024 21:03: JST
|
|
|
UK's Largest EV Show Returns for 4th Edition Driving Innovation with Policy Leaders, Product Launches, and EV Innovations
Apr 19, 2024 20:03 HKT/SGT
|
|
|
GLOBE LIFE (GL): Kaplan Fox & Kilsheimer LLP Investigates GLOBE LIFE and Encourages Investors to Contact the Firm
Apr 19, 2024 20:00 HKT/SGT
|
|
|
SMC Announces Marketing Agreement with Plato Technologies. Inc.
Apr 19, 2024 16:03 HKT/SGT
|
|
|
First-ever Mazda CX-80 Crossover SUV Unveiled in Europe
Apr 19, 2024 13:50 JST
|
|
|
Prestigious titles for top developers at the 14th PropertyGuru Asia Property Awards (Singapore)
Apr 19, 2024 11:30 HKT/SGT
|
|
|
Revolutionizing Tomorrow: Uniting Visionaries at the 2024 Digital Transformation Summit Philippines
Apr 19, 2024 11:23 HKT/SGT
|
|
|
朝雲集團(06601.HK):穩健增長與高派息策略共驅,多家頭部券商給予增持評級
Apr 19, 2024 10:24 HKT/SGT
|
|
|
22nd Edition of Cyber Security Summit: Thailand to Convene Esteemed Panel of Industry Leaders
Apr 19, 2024 10:11 HKT/SGT
|
|
|
The Rapidly Evolving Real Estate Landscape: Redefine Real Estate Summit Connects Key Players in South East Asia
Apr 19, 2024 10:11 HKT/SGT
|
|
|
富士通、世界初 形式の異なる企業のデジタルアイデンティティー証明書を変換する技術を開発し欧州データスペースへの接続実証に成功
Apr 19, 2024 10:00: JST
|
|
|
Fujitsu develops technology to convert corporate digital identity credentials, enabling participation of non-European companies in European data spaces
Apr 19, 2024 10:17 JST
|
|
|
Rapid Evolution in Philippines' BFSI Sector: BFSI IT Summit 2024 to Illuminate Transformation
Apr 19, 2024 08:02 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|